FDA needs to loosen up on CBD but clamp down on quality claims

The FDA is developing regulations around hemp-derived products that contain CBD. It currently bans from interstate commerce any foods and beverages to which CBD has been added as an …

May, 2019

GW Pharmaceuticals stock rises 6% after positive CBD drug trial

Original Source: GW Pharmaceuticals stock rises 6% after positive CBD drug trial GW Pharmaceuticals PLC GWPH, +2.62% said late Monday that it had a positive phase-three trial result for …